Amanda Andrews
Neurology with Special Qualifications in Child Neurology · Augusta, GANPI 1285098368
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 57 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 13.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $620 and has fallen 92.9% since, to $44 in 2025. That places this record below the midpoint for neurology with special qualifications in child neurology clinicians in GA, where the typical reported total is $1,448.
Across 57 payments — averaging $22.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- SK Life Science, Inc.$174
- Tanabe Pharma America, Inc.$110
- AstraZeneca$101
- Neurelis, Inc.$93
- Sarepta Therapeutics, Inc.$89
- Merz Pharmaceuticals, LLC$77
- plus $613 from 17 others
What the payments were for
- Food & beverage$1,256100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| SK Life Science, Inc. | 6 | $174 |
| Tanabe Pharma America, Inc. | 6 | $110 |
| AstraZeneca | 5 | $101 |
| Neurelis, Inc. | 4 | $93 |
| Sarepta Therapeutics, Inc. | 4 | $89 |
| Merz Pharmaceuticals, LLC | 3 | $77 |
| UCB, Inc. | 4 | $69 |
| Jazz Pharmaceuticals Inc. | 2 | $64 |
| Amgen | 2 | $52 |
| Genentech USA, Inc. | 2 | $51 |
| ITF Therapeutics LLC | 2 | $49 |
| Eisai Inc. | 2 | $44 |
| Ipsen Biopharmaceuticals, Inc | 2 | $39 |
| Catalyst Pharmaceuticals, Inc. | 2 | $38 |
| Livanova USA, Inc. | 2 | $34 |
| CSL Behring | 1 | $32 |
| Supernus Pharmaceuticals, Inc. | 2 | $32 |
| Argenx US, Inc. | 1 | $27 |
| Akcea Therapeutics, Inc. | 1 | $20 |
| Sanofi | 1 | $18 |
| Biogen | 1 | $15 |
| NS Pharma, Inc. | 1 | $15 |
| Octapharma USA, Inc. | 1 | $14 |
How this compares
$1,256 in reported general payments places this provider in the 40th percentile of 41 neurology with special qualifications in child neurology providers in Georgia.
See all neurology with special qualifications in child neurology providers in Georgia →
Other neurology with special qualifications in child neurology in Augusta
- Yong ParkAugusta$78K
- Elizabeth SekulAugusta$8K
- Suzanne StricklandAugusta$8K
- Marleny Aquino CabreraAugusta$5K
- Abdelrahim AbdelAugusta$1K
- James CarrollAugusta$22
- Bernard MariaAugusta$17
- John HemphillSavannah$2M
- Chaouki KhouryAtlanta$978K
- Katherine MoretzSavannah$144K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.